Genentech: Baris Bingol

Por um escritor misterioso
Last updated 10 novembro 2024
Genentech: Baris Bingol
I am proud to be part of the scientific team at Genentech that values scientific excellence above all to fuel therapeutic programs for patients in need.
Genentech: Baris Bingol
The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy
Genentech: Baris Bingol
Baris BINGOL, Genentech, California, Department of Neuroscience
Genentech: Baris Bingol
Antibody News
Genentech: Baris Bingol
Ocular phenotypes in a mouse model of impaired glucocerebrosidase activity
Genentech: Baris Bingol
Genentech: Domagoj Vucic Senior Fellow, Immunology Discovery
Genentech: Baris Bingol
Genentech: Casper Hoogenraad VP Neuroscience, Neuroscience
Genentech: Baris Bingol
Keystone Symposia Scientific Conferences on Biomedical and Life Science Topics
Genentech: Baris Bingol
Genentech: Our Scientists
Genentech: Baris Bingol
WO2014041111A1 - Usp30 inhibitors and methods of use - Google Patents
Genentech: Baris Bingol
The mitochondrial deubiquitinase USP30 opposes parkin--ediated mitophagy - Document - Gale OneFile: Health and Medicine

© 2014-2024 citytv24.com. All rights reserved.